About DUKADA

DUKADA has been active since 2012 in the development, manufacturing and marketing of add-ons for injection pens.

The first product, DUKADA Trio, was introduced as a consumer solution to support users of insulin pens, notably some from Novo Nordisk and Sanofi.

Over time, the company has shifted its focus to B2B solutions, offering adaptable and connected add-ons for a wider range of injection pen treatments.

Today, DUKADA provides smart cap solutions such as DUKADA Sense, designed to enhance usability, support treatment adherence and enable eHealth integration across therapeutic areas.

Technical Team

DUKADA coordinates a specialised team of experts with deep experience in medtech and connected devices. Their expertise covers all key areas required for the development and production of high-quality add-ons for injection pens.

Management

Jakob Dahl Thomsen, CEO

Jakob Dahl Thomsen, the co-founder of DUKADA ApS participates in the New York-based LyfeBulb Entrepreneur Circle. This Circle is an inspirational platform for all people living with or affected by a chronic disease.

Preparing Dukada Caps to be connected to diabetes apps

Board of Directors

Jakob Dahl Thomsen, CEO, Business and Legal Advisor
Ole Høj, CEO, Hoy Holding ApS
Alicia Rubinat, Architect

Sales and Customisation

Stand out with Smart Cap solutions for injection pens – visit our Partnering page or contact us at [email protected].

Company info

DUKADA ApS
Krogholmen 9
DK-2840 Holte
Denmark
Tlf: +45 53510201
Company number: DK34589844

About DUKADA

Since 2012, DUKADA has developed smart cap solutions for injection pens, enhancing usability and enabling eHealth integration – in collaboration with pen producers and pharmaceutical companies.

More about DUKADA

The first product, DUKADA Trio, was introduced as a consumer solution to support users of insulin pens, notably some from Novo Nordisk and Sanofi.